Your browser doesn't support javascript.
loading
CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951.
Sirvent, N; Suciu, S; De Moerloose, B; Ferster, A; Mazingue, F; Plat, G; Yakouben, K; Uyttebroeck, A; Paillard, C; Costa, V; Simon, P; Pluchart, C; Poirée, M; Minckes, O; Millot, F; Freycon, C; Maes, P; Hoyoux, C; Cavé, H; Rohrlich, P; Bertrand, Y; Benoit, Y.
Afiliação
  • Sirvent N; Department of Pediatric Hematology-Oncology, CHU, Montpellier, France; University Montpellier, Montpellier, France. Electronic address: n-sirvent@chu-montpellier.fr.
  • Suciu S; EORTC Headquarters, Brussels, Belgium.
  • De Moerloose B; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent University, Ghent, Belgium.
  • Ferster A; Department of Pediatric Hematology-Oncology, Children's University Hospital Queen Fabiola, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Mazingue F; Department of Pediatric Hematology-Oncology, CHRU, Lille, France.
  • Plat G; Department of Pediatric Hematology-Oncology, CHU-Hôpital Purpan, Toulouse, France.
  • Yakouben K; Department of Pediatric Hematology, Robert-Debré Hospital, AP-HP, Paris, France.
  • Uyttebroeck A; Department of Pediatric Hematology-Oncology, University Hospital Gasthuisberg, Leuven, Belgium.
  • Paillard C; Department of Pediatric Hematology-Oncology, University Hospital Hautepierre, Strasbourg, France.
  • Costa V; Department of Pediatrics, Portuguese Oncology Institute, Porto, Portugal.
  • Simon P; Pediatric Hematology Unit, CHU Jean-Minjoz Hospital, Besançon, France.
  • Pluchart C; Department of Pediatric Hematology-Oncology, American Memorial Hospital, Reims, France.
  • Poirée M; Department of Pediatric Hematology-Oncology, CHU Nice, Nice, France.
  • Minckes O; Department of Pediatric Hematology-Oncology, CHU, Caen, France.
  • Millot F; Pediatric Oncology Unit, University Hospital, Poitiers, France.
  • Freycon C; Department of Pediatric Oncology, University Hospital, Grenoble, France.
  • Maes P; Department of Pediatrics, University Hospital Antwerp, Antwerp, Belgium.
  • Hoyoux C; Department of Pediatrics, CHR de la Citadelle, Liège, Belgium.
  • Cavé H; Department of Genetics, Assistance publique-Hôpitaux de Paris (AP-HP), Robert-Debré Hospital, Paris, France; INSERM UMR 1131, University Institute of Hematology, University Paris-Diderot, Paris Sorbonne Cité, Paris, France.
  • Rohrlich P; Department of Pediatric Hematology-Oncology, CHU Nice, Nice, France.
  • Bertrand Y; Institute of Pediatric Hematology and Oncology (IHOP), Hospices Civils de Lyon, University Lyon 1, Lyon, France.
  • Benoit Y; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent University, Ghent, Belgium.
Arch Pediatr ; 28(5): 411-416, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34034929
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Nervoso Central / Valor Preditivo dos Testes / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Arch Pediatr Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Nervoso Central / Valor Preditivo dos Testes / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Arch Pediatr Ano de publicação: 2021 Tipo de documento: Article